Table 2.
Antibacterial activity of fatty acids against C. difficile strain R20291.
| Number of carbon backbone | General name | MIC (mg/ml) | MBC (mg/ml) | pH (in BHIS) | |
|---|---|---|---|---|---|
| SCFAs | C3 | Propionic acid | 1.25 | 5 | 3.91 |
| C4 | Butyric acid | 25 | 50 | 7.11 | |
| C4 | Isobutyric acid | 1.25 | 5 | 4.97 | |
| C5 | Valeric acid | 1.25 | 2.5 | 5.78 | |
| C5 | Isovaleric acid | 2.5 | 2.5 | 5.76 | |
| MCFAs | C6 | Hexanoic acid | 1.25 | 2.5 | 5.94 |
| C8 | Octanoic acid | 2.5 | 5 | 5.51 | |
| C10 | Capric acid | 0.63 | 1.25 | 6.81 | |
| C12 | Lauric acid | 0.31 | 0.31 | 6.91 | |
| LCFAs | C14 | Myristic acid | >10 | >10 | 6.51 |
| C16 | Palmitic acid | 10 | 10 | 6.77 |
Clostridium difficile strain R20291 was exposed to various dilutions of different fatty acids for 24 h, and MBC was determined as the concentration of fatty acids at which no visible growth was observed. Results are expressed as average of at least three independent replicates. SCFA, short-chain fatty acids; MCFA, medium-chain fatty acids; LCFA, long-chain fatty acids.